SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001654954-19-011771
Filing Date
2019-10-15
Accepted
2019-10-15 16:11:42
Documents
1
Period of Report
2019-10-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 3  
1 PRIMARY DOCUMENT section16.xml 3 1305
  Complete submission text file 0001654954-19-011771.txt   2821
Mailing Address 1400 31ST AVENUE SW, SUITE 60 MINOT ND 58701
Business Address
Schafer Edward T (Reporting) CIK: 0001376093 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36498 | Film No.: 191151077

Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (347) 905 5663
Cellular Biomedicine Group, Inc. (Issuer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)